19th December 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Minal Patel convicted in alleged $447 genetic testing fraud

An Indian American Minal Patel, owner of LabSolutions LLC from Atlanta has conspired with patient brokers, telemedicine companies, and call centers to target Medicare beneficiaries and sell their fake medicare package, as alleged by federal prosecutors.

Widely used neuropathic pain drugs Gabapentin and Pregabalin to be under PV scanner

Drug regulators in India have sought help from pharmacovigilance (PV) for neuropathic pain drugs Gabapentin and Pregabalin due to cardiovascular-related adverse drug reactions giving reference to a study published in the American Medical Journal Cardiovascular Diabetology.

India might become research hub in pharma sector : Union Health Minister

At the inaugural function of the ICMR – National Animal Resource Facility for Biomedical Research at Genome Valley, Union Health Minister Mansukh Mandaviya mentioned that India is the pharmacy of the world and the center would like to see the country rise as a research hub in the pharma sector.

Dr. Reddy's subsidiary inks pact to sell some assets of Netherlands-based facility

On Saturday, Dr. Reddy’s Labs informed that its subsidiary DRRDBV had signed an asset purchase agreement with Delpharm Development Leiden BV to sell certain assets and liabilities of its Netherlands-based site.

EU's watchdog recommends Sanofi's drug Dupixent for Oesophagus illness

Pharma major Sanofi announced that European Union’s drug watchdog has recommended its blockbuster drug Dupixent for approval for treating an allergic condition of the Oesophagus.

CHMP recommends marketing approval for ViiV Healthcare's dispersible tablet formulation

ViiV Healthcare has declared that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion advocating marketing authorization for Triumeq PD indicated for the treatment of pediatric patients with HIV-1.

DoP nominates OSD to accelerate the process of setting up EPC for medical devices

The Department of Pharmaceuticals (DoP) has recently designated Pallavi Saha from the Engineering Export Promotion Council (EEPC) as the new OSD (Officer on Special Duty) to hasten the process of setting up of the Export Promotion Council for medical devices (EPC-MD)

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?